Next Leap Inc. – Trademark Portfolio

Entity Type: 03

Next Leap Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 3 are pending. Notable registered marks include EOA and END OF AGING. The owner is based in Seoul.

67-gil, Yeongdeungpo-gu

D9-ho, 5F, 11, Yeouidaebang-ro

Seoul 07333 , KR

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EOA
EOA
Pending 2024
EOA
EOA
Registered 2024

Trademark Classifications

Next Leap Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Next Leap Inc. have?

Next Leap Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 pending.

What trademark classes does Next Leap Inc. file in?

Next Leap Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Next Leap Inc.'s most well-known trademarks?

Next Leap Inc.'s registered trademark portfolio includes well-known marks such as EOA and END OF AGING. These are among 2 currently registered trademarks in the portfolio.

What is Next Leap Inc.'s trademark registration success rate?

Next Leap Inc. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 3 applications are pending review.